The CTD² Network and Cancer Systems Biology Consortium organized a virtual symposium series titled “Multidisciplinary Approaches to Understand Cancer Treatment Resistance”. Registration will open in mid-October for all symposium dates; please join us on 11/16, 11/17, 12/2, 12/16, and 12/17. Click here to view the draft agenda.
CTD² Data Portal
Last Updated: August 19, 2020
The CTD2 Network aims to understand the tumor heterogeneity and drug resistance for the development of efficient strategies to identify optimal combinations of small-molecules or immunotherapy with small molecules. The CTD2 Data Portal provides access to raw/analyzed primary data generated from different types of approaches e.g. chemical genetics (small-molecules, natural products); genome-wide gain-of-function (cDNA expression libraries, CRISPRa); genome-wide loss-of-function (siRNA, shRNA, CRISPR/Cas9, CRISPRi); protein-protein interactions; and in vivo gain and loss-of function studies.
There are currently {{row_count}} datasets and can be sorted by Center or the assay type.
Users must use data with discretion and acknowledge the CTD2 Network.
{{row.dpp.title}}
Experimental Approaches
{{approach.dpp_title}}
{{approach.dpp_body.length > 150 ? 'Read More...' : ''}}
Principal Investigator
{{investigator.investigator}}
Contact Name
Reference
{{row.dpp_title}}
Experimental Approaches
{{approach.dpp_title}}
{{approach.dpp_body.length > 150 ? 'Read More...' : ''}}
Principal Investigator
{{investigator.investigator}}